Literature DB >> 18992617

The medical and oncological rationale for partial nephrectomy for the treatment of T1 renal cortical tumors.

Paul Russo1, William Huang.   

Abstract

This article presents the oncological and medical rationale for partial nephrectomy as the treatment of choice whenever possible for T1 renal tumors. The value of partial nephrectomy in the management of small renal cortical tumors is gaining wider recognition thanks to (1) enhanced understanding of the biology of renal cortical tumors; (2) better knowledge about tumor size and stage migration to small tumors at the time of presentation; (3) studies indicating the oncologic efficacy of kidney-sparing surgery, and (4) increasing awareness of the wide prevalence of chronic kidney disease. The overzealous use of radical nephrectomy for small renal tumors must now be considered detrimental to the long-term health and safety of the patient with a small renal cortical tumor.

Entities:  

Mesh:

Year:  2008        PMID: 18992617     DOI: 10.1016/j.ucl.2008.07.008

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  20 in total

1.  Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.

Authors:  Jeremiah J Morrissey; Vincent M Mellnick; Jingqin Luo; Marilyn J Siegel; R Sherburne Figenshau; Sam Bhayani; Evan D Kharasch
Journal:  JAMA Oncol       Date:  2015-05       Impact factor: 31.777

2.  American Confederation of Urology (CAU) experience in minimally invasive partial nephrectomy.

Authors:  Fernando P Secin; Octavio A Castillo; José J Rozanec; Marcelo Featherston; Pablo Holst; José Cocisfran Alves Milfont; Patricio García Marchiñena; Alberto Jurado Navarro; Anamaría Autrán; Agustín R Rovegno; Oscar Rodríguez Faba; Joan Palou; Victor Teixeira Dubeux; Luciano Nuñez Bragayrac; Rene Sotelo; Stenio Zequi; Gustavo Cardoso Guimarães; Mario Álvarez-Maestro; Luis Martínez-Piñeiro; Gustavo Villoldo; Alberto Villaronga; Diego Abreu Clavijo; Ricardo Decia; Rodrigo Frota; Ivar Vidal-Mora; Diana Finkelstein; Juan I Monzó Gardiner; Oscar Schatloff; Andres Hernández-Porrás; Félix Santaella-Torres; Emilio T Quesada; Rodolfo Sánchez-Salas; Hugo Dávila; Humberto Villavicencio Mavric
Journal:  World J Urol       Date:  2016-04-30       Impact factor: 4.226

Review 3.  Open partial nephrectomy: ancient art or currently available technique?

Authors:  Mauro Seveso; Fabio Grizzi; Giorgio Bozzini; Alberto Mandressi; Giorgio Guazzoni; Gianluigi Taverna
Journal:  Int Urol Nephrol       Date:  2015-10-05       Impact factor: 2.370

4.  The changing face of renal-cell carcinoma.

Authors:  Gennady Bratslavsky; Ziya Kirkali
Journal:  J Endourol       Date:  2010-05       Impact factor: 2.942

5.  Urinary biomarkers for the early diagnosis of kidney cancer.

Authors:  Jeremiah J Morrissey; Amy N London; Jingqin Luo; Evan D Kharasch
Journal:  Mayo Clin Proc       Date:  2010-04-07       Impact factor: 7.616

6.  Comparison of robotic and open partial nephrectomy: Single-surgeon matched cohort study.

Authors:  Jong Jin Oh; Seoksoo Byun; Sung Kyu Hong; Chang Wook Jeong; Sang Eun Lee
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862

Review 7.  Current Status of Nephron-Sparing Surgery (NSS) in the Management of Renal Tumours.

Authors:  Vivek Venkatramani; Sanjaya Swain; Ramgopal Satyanarayana; Dipen J Parekh
Journal:  Indian J Surg Oncol       Date:  2017-01-30

8.  Contemporary clinical epidemiology of renal cell carcinoma: insight from a population based case-control study.

Authors:  David C Miller; Julie Ruterbusch; Joanne S Colt; Faith G Davis; W Marston Linehan; Wong-Ho Chow; Kendra Schwartz
Journal:  J Urol       Date:  2010-10-16       Impact factor: 7.450

9.  Residual renal function after partial or radical nephrectomy for renal cell carcinoma.

Authors:  David Chapman; Ron Moore; Scott Klarenbach; Branko Braam
Journal:  Can Urol Assoc J       Date:  2010-10       Impact factor: 1.862

Review 10.  Oncological and renal medical importance of kidney-sparing surgery.

Authors:  Paul Russo
Journal:  Nat Rev Urol       Date:  2013-03-05       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.